BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.
-
Upload
gordon-roberts -
Category
Documents
-
view
215 -
download
0
Transcript of BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.
![Page 1: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/1.jpg)
BIOSIGNAL Pty LtdBIOSIGNAL Pty Ltd
Tove Ringbom Lotta Ekman
Business Plan Evaluation
![Page 2: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/2.jpg)
What is a biofilm?What is a biofilm?
• Biofilms are colonies of living micro-organisms (e.g., bacteria, fungi, algae, and/or protozoa) growing on any surface (e.g. metals, plastics, tissue, soil particles, teeth, and so forth)
![Page 3: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/3.jpg)
BiofilmsBiofilms
![Page 4: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/4.jpg)
How are biofilms formed?How are biofilms formed?
http://www.crca.asn.au/activities/2002/conference/Plenary2/Jasjit/Biofilm_Jasjit.swf
![Page 5: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/5.jpg)
Biofilm infectionsBiofilm infections
• cause dental cavities, gum disease, as well as ear-, heart- and lung infections
• Biofilms also form on contact lenses and on intrauterine birth control devises
• Biofilms on the inner surfaces of medical equipment (catheters) hospital infections
![Page 6: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/6.jpg)
![Page 7: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/7.jpg)
The InnovationThe Innovation
The seaweed (Delisea pulchra) remains slime-free due to the production of furanones
Biosignal has patented synthetic analogs of these furanones
Furanones prevent bacteria from attaching to surfaces no biofilm formation
![Page 8: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/8.jpg)
http://www.crca.asn.au/activities/2002/conference/Plenary2/Jasjit/PreventionJasjit.swf
![Page 9: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/9.jpg)
Business OpportunityBusiness Opportunity
• By attaching furanones to polymers, biofilm formation could be prevented in
1) marine and agriculture usages
2) bound to polymer coatings
3) in implantable medical devices such as catheters
![Page 10: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/10.jpg)
Evaluating the Business PlanEvaluating the Business Plan
• Plan dated December 6th 2000
• Clear purpose stated
- $5.3 million to expand R&D
- to hire an experienced chief executive officer
- raise money in order to register its patented compounds with the EPA and FDA
![Page 11: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/11.jpg)
ManagementManagement
• Biosignal lacks a CEO at the moment
Demanding requirements
• An experienced polymer chemist must be hired
• Professors Kjellberg & Steinberg possess scientific experience in the field of marine biology and microbiology
• GM Rohan McDougall
![Page 12: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/12.jpg)
Market AssessmentMarket Assessment
• Biosignal found six different areas of interest:- Household cleaners - Oral care - Contact lens solutions - Anti-foulant in marine paint - Commercial farming applications - Biomaterials
![Page 13: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/13.jpg)
RisksRisks
• Biosignals technology may fail to deliver on its early promises
• The safety risks to patients and to the environment are not known at this point
![Page 14: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/14.jpg)
Segment for first market entry Segment for first market entry
• Catheter market
• The medical grade polymers demonstrate the greatest revenue opportunity of the six different options
• The catheter market is growing rapidly, as is the total biomaterials market
• Reason for choosing the segment: the disposable catheter is a relatively simple device
ambition is to move to more technologically advanced medical devices at a later stage
![Page 15: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/15.jpg)
Competitor InformationCompetitor Information
• 156 companies operate on the global catheter market today
• Several multinational polymer giants operate in this field
• PROBLEM: big organizations such as hospitals generally make group purchases and catheters are often priced as a part of a bundle of products
![Page 16: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/16.jpg)
CollaborationsCollaborations
• Biosignal gets office space and lab space support from UNSW and the two Research Directors are employed part time by UNSW
• A cooperation project to manufacture Biosignal’s product with an “American specialty chemical manufacturer”
• Multinational partners are key success factors for this venture
![Page 17: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/17.jpg)
FinancialsFinancials
• Biosignal has established connections to a few companies
• Estimated personnel expenses may not be big enough
• R&D expenses ought to rise as time goes by - Biosignal is aware
![Page 18: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/18.jpg)
Our conclusion Our conclusion
• Start with any of the applications that are outside the human body to get cash flow
• The biomaterials market is very tricky
• Get experience in manufacturing, sales and running a business before entering the markets that require FDA approval
![Page 19: BIOSIGNAL Pty Ltd Tove Ringbom Lotta Ekman Business Plan Evaluation.](https://reader035.fdocuments.in/reader035/viewer/2022062421/56649da25503460f94a8f241/html5/thumbnails/19.jpg)
THANKYOU!
THANKYOU!